These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4146210)

  • 21. [Studies on tetraethyl lead intoxication. Part 1. The effects of sleeping-waking cycle in rat (author's transl)].
    Matsumoto K; Matsui T; Kawamori M
    Nihon Eiseigaku Zasshi; 1979 Dec; 34(5):670-6. PubMed ID: 544845
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of cadmium on the structure of the circadian cycle of waking-sleep and on the EEG in Wistar rats].
    Vataev SI; Mal'gina NA; Oganesian GA
    Zh Evol Biokhim Fiziol; 1994; 30(3):408-19. PubMed ID: 7810264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the rat.
    Scheller D; Dürmüller N; Moser P; Porsolt RD
    Eur J Pharmacol; 2008 Apr; 584(1):111-7. PubMed ID: 18304531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. 1. On the sleepwaking cycles.
    Laguzzi RF; Adrien J; Bourgoin S; Hamon M
    Brain Res; 1979 Jan; 160(3):445-59. PubMed ID: 217478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of intracerebral 6-hydroxy dopamine on 3H-reserpine binding to different brain regions of the rat.
    Mennini T; Bernasconi S; Manara L; Samanin R; Serra G
    Pharmacol Res Commun; 1977 Oct; 9(9):857-62. PubMed ID: 609579
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of monoamines in the regulation of alertness. Neurophysiological and biochemical study].
    Jouvet M; Pujol JF
    Rev Neurol (Paris); 1972 Jul; 127(1):115-38. PubMed ID: 4358571
    [No Abstract]   [Full Text] [Related]  

  • 27. Loss of visual placing in rats after lateral hypothalamic microinjections of 6-hydroxydopamine.
    Sechzer JA; Ervin GN; Smith GP
    Exp Neurol; 1973 Dec; 41(3):723-37. PubMed ID: 4586282
    [No Abstract]   [Full Text] [Related]  

  • 28. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 29. Excretion of catecholamine metabolites following intraventricular injection of 6-hydroxydopamine in the Macaca speciosa.
    Maas JW; Dekirmenjian H; Garver D; Redmond DE; Landis DH
    Eur J Pharmacol; 1973 Aug; 23(2):121-30. PubMed ID: 4200289
    [No Abstract]   [Full Text] [Related]  

  • 30. Tyrosine hydroxylase activity in brain regions after intraventricular 6-hydroxydopamine in the neonatal rat.
    Peters DA; Pappas BA; Taub H; Saari M
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):161-4. PubMed ID: 28554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central muscarinic receptor degeneration following 6-hydroxydopamine lesion in mice.
    Gurwitz D; Kloog Y; Egozi Y; Sokolovsky M
    Life Sci; 1980 Jan; 26(1):79-84. PubMed ID: 7360000
    [No Abstract]   [Full Text] [Related]  

  • 32. 5-hydroxytryptophan and the sleep-wakefulness cycle in rabbits.
    Tabushi K; Himwich HE
    Biol Psychiatry; 1970 Apr; 2(2):183-8. PubMed ID: 5311731
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of application of gamma amino butyric acid at the medial preoptic area on sleep-wakefulness.
    Chari DM; Ramesh V; John J; Kumar VM
    Indian J Physiol Pharmacol; 1995 Jul; 39(3):299-301. PubMed ID: 8550132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reflection of tolerance to alcohol in the structure of the sleep wakefulness cycle.
    Gogichadze M; Nemsadze M; Lortkipanidze N; Khachaturovy E; Oniani N
    Georgian Med News; 2014 Oct; (235):87-92. PubMed ID: 25416225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of unilateral destruction of the caudate nucleus with kainic acid on the nature of the electrical activity in the rat brain in the wakefulness-sleep cycle].
    Vataev SI; Titkov ES; Oganesian GA
    Zh Evol Biokhim Fiziol; 1996; 32(5):613-9. PubMed ID: 9092238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intraventricular administration of noradrenaline and dopamine on the levels of corticosterone in rats and denervation hypersensitivity resulting from intraventricular administration of 6-hydroxydopamine.
    Kawa A; Taniguchi Y; Mizuguchi K; Ryu S; Ariyama T; Kamisaki T; Koreeda F; Kanehisa T
    Life Sci; 1978 Sep; 23(9):991-7. PubMed ID: 703530
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of selective activation or blockade of the histamine H3 receptor on sleep and wakefulness.
    Monti JM; Jantos H; Boussard M; Altier H; Orellana C; Olivera S
    Eur J Pharmacol; 1991 Dec; 205(3):283-7. PubMed ID: 1667912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of a GABA(B) and GABA(C) receptor antagonist on sleep-waking cycle in the rat.
    Deschaux O; Froestl W; Gottesmann C
    Eur J Pharmacol; 2006 Mar; 535(1-3):177-81. PubMed ID: 16540106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system.
    Hökfelt T; Ungerstedt U
    Brain Res; 1973 Oct; 60(2):269-97. PubMed ID: 4763613
    [No Abstract]   [Full Text] [Related]  

  • 40. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis.
    Santucci V; Storme JJ; Soubrié P; Le Fur G
    Life Sci; 1996; 58(6):PL103-10. PubMed ID: 8569415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.